An international collaboration - involving the University of Liege, the University Hospital of Liege and the CHC Mont Légia - has identified several genetic markers associated with SARS-CoV-2 infection and COVID-19 severity.
A study lead by Danish and Belgian (GIGA/ULiège) researchers attributes for the first time a biological purpose to near-death experiences (NDEs)
Awarded by the King Baudouin Foundation, this fund will enable her to continue her research, that aims at a better understanding of multiple sclerosis pathophysiology.
A high level partnership between the universities of Liège, Aachen, Maastricht and Venlo (UM campus) in which GIGA and Montefiore researchers will contribute their experience in biostatistics, biomedicine and bioinformatics.
Most of post-comatose clinically unresponsive patients present residual brain activity closer to what we usually observe in minimally conscious patients.
Jean-Claude Twizere's team (Laboratory of Viral Interactomes, GIGA-MBD) explains in Science Advances the regulation of the dynamics of the endoplasmic reticulum and the extension of its tubular network in mammalian cells.
According to a study by the European "Meditaging" consortium including GIGA-CRC in vivo Imaging, meditation has beneficial effects on the mental health of seniors.
This grant will allow her to continue his research in the field of oncology and more specifically in triple negative breast cancer (TNBC)
A new study shows that heart brain interactions, measured using electroencephalography (EEG), provide a novel diagnostic avenue for patients with disorders of consciousness.
In an article published in Nature Communications, Francesca Rapino & Pierre Close, from the Laboratory of Cancer Signaling (GIGA), discover how the modification of transfer RNAs impacts the dynamics of protein expression.
The Alzheimer's Research Foundation has selected three research projects at the University of Liège for a total of 600,000 euros, out of the 3,200,000 euros granted by the Foundation in Belgium.
The company CMD-Coat S.A., born from a collaboration between the GIGA (GIGA-Cardiovascular), the CHU (cardiology service) and the ULiège chemistry department, was officially born this 25th March.